![本周財經市場5件大事:美國非農、鮑威爾講話、聯儲局紀要重磅來襲](https://i-invdn-com.investing.com/news/moved_small-LYNXNPEK340EF_L.jpg)
注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
PaxMedica Inc是一家臨床階段的生物製藥公司。該公司專注於開發抗嘌呤能藥物療法(APT),用於治療具有難治性神經症狀的疾病,包括神經發育障礙,包括自閉症譜系障礙(ASD),以及肌痛性腦脊髓炎/慢性疲勞綜合徵(ME/CFS)。其候選產品包括PAX-101和PAX-102。其主要項目PAX-01是蘇拉明的靜脈製劑,用於治療ASD,並提高對使用該藥物治療其他疾病的臨床理解,例如ME/CFS和長新冠肺炎綜合徵(LCS)。該公司還專注於開發PAX-101用於治療東非人非洲錐蟲病(HAT),該病由寄生蟲布氏羅得西亞錐蟲引起。它還專注於開發PAX-102,這是用於神經適應症的蘇拉明鼻內製劑。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Constance Smith-Hicks | - | - | Member of Scientific Advisory Board |
Zachary Rome | 39 | 2019 | Director |
Reymundo Lozano | - | - | Member of Advisory Board |
Alice Mao | - | - | Member of Scientific Advisory Board |
Veronica Martinez Cerdeno | - | - | Member of Advisory Board |
Andrew J. Cutler | - | 2023 | Member of Scientific Advisory Board |
John F. Coelho | 54 | 2022 | Independent Director |
Charles J. Casamento | 78 | 2022 | Lead Independent Director |
Robert K. Naviaux | - | - | Member of Scientific Advisory Board |
Vladimir Maletic | - | 2023 | Member of Scientific Advisory Board |
Rakesh Jain | - | 2023 | Member of Scientific Advisory Board |
Robert Findling | - | 2023 | Member of Scientific Advisory Board |
Karen J. LaRochelle | 56 | 2020 | Independent Director |
Michael Aman | - | - | Member of Scientific Advisory Board |
Stefan K. F. Schwabe | 71 | 2022 | Member of Scientific Advisory Board |
Howard J. Weisman | 64 | 2020 | CEO & Chairman |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核